Eureka projects

The scope of this project is to complete the r&d required for obtaining the market authorization of a new recombinant vaccine against canine leishmaniasis, which has been shown protective in experimental trials in dogs with better performance than that of gold-standards.
Project ID: 

To find a technical-economical solution that allows the scale up in nanocellulose production, overcoming the current problems like very low capacity per production unit, extremely high amounts of energy needed per ton of product and others.
Project ID: 

Raising the productivity and competitiveness of European businesses through technology. Boosting national economies on the international market, and strengthening the basis for sustainable prosperity and employment.